Evidence map›Paper›PMID 32639540›Full record

ArticleThe Journal of experimental medicine2020

Mutations in the exocyst component EXOC2 cause severe defects in human brain development.

Nicole J Van Bergen, Syed Mukhtar Ahmed, Felicity Collins, Mark Cowley, Annalisa Vetro, Russell C Dale, Daniella H Hock, Christian de Caestecker, Minal Menezes, Sean Massey and 9 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 3 countries.

Nicole J Van BergenBrain and Mitochondrial Research Group, Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia.
Syed Mukhtar AhmedDepartment of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN.
Felicity CollinsWestern Sydney Genetics Program, Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Mark CowleyKinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
Annalisa VetroPediatric Neurology, Neurogenetics and Neurobiology Unit and Laboratories, Meyer Children's Hospital, University of Florence, Florence, Italy.
Russell C DaleDepartment of Paediatric Neurology, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Daniella H HockDepartment of Biochemistry and Molecular Biology and The Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia.
Christian de CaesteckerDepartment of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN.
Minal MenezesKids Research, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Sean MasseyBrain and Mitochondrial Research Group, Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia.
Gladys HoWestern Sydney Genetics Program, Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Tiziana PisanoPediatric Neurology, Neurogenetics and Neurobiology Unit and Laboratories, Meyer Children's Hospital, University of Florence, Florence, Italy.
Seana GloverBrain and Mitochondrial Research Group, Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia.
Jovanka GusmanBrain and Mitochondrial Research Group, Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia.
David A StroudDepartment of Biochemistry and Molecular Biology and The Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia.
Marcel DingerKinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
Renzo GuerriniPediatric Neurology, Neurogenetics and Neurobiology Unit and Laboratories, Meyer Children's Hospital, University of Florence, Florence, Italy.
Ian G MacaraDepartment of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN.
John ChristodoulouBrain and Mitochondrial Research Group, Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia.
Royal Children's Hospital · AUMeyer Children's Hospital · ITVanderbilt University · USChildren's Hospital at Westmead · AUGarvan Institute of Medical Research · AUThe University of Melbourne · AURoyal Prince Alfred Hospital · AUThe University of Sydney · AU

Funding

MECHANISMS OF CELL POLARITY ESTABLISHMENTR01GM070902 · NIGMS · VANDERBILT UNIVERSITY · PI MACARA, IAN G · 2004 to 2022
$5.4M
NIGMS NIH HHS R01 GM070902
6 · The paper itself

Abstract

The exocyst, an octameric protein complex, is an essential component of the membrane transport machinery required for tethering and fusion of vesicles at the plasma membrane. We report pathogenic variants in an exocyst subunit, EXOC2 (Sec5). Affected individuals have severe developmental delay, dysmorphism, and brain abnormalities; variability associated with epilepsy; and poor motor skills. Family 1 had two offspring with a homozygous truncating variant in EXOC2 that leads to nonsense-mediated decay of EXOC2 transcript, a severe reduction in exocytosis and vesicle fusion, and undetectable levels of EXOC2 protein. The patient from Family 2 had a milder clinical phenotype and reduced exocytosis. Cells from both patients showed defective Arl13b localization to the primary cilium. The discovery of mutations that partially disable exocyst function provides valuable insight into this essential protein complex in neural development. Since EXOC2 and other exocyst complex subunits are critical to neuronal function, our findings suggest that EXOC2 variants are the cause of the patients' neurological disorders.

Indexed as

BrainDevelopmental DisabilitiesFemaleHumansInfantInfant, NewbornMagnetic Resonance ImagingMaleMicrocephalyMutationNeuroimagingPedigreeSequence Analysis, DNAVesicular Transport ProteinsEXOC2 protein, humanVesicular Transport Proteins

Identifiers

PMID32639540
PMCPMC7537385
OpenAlexW3041984968

What Socratic holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.